Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,075 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma

NCT00006021

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Cedars Medical Center Miami, Florida, United States
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Baptist-South Miami Regional Cancer Program Miami, Florida, United States
  • Mount Sinai Comprehensive Cancer Center at Mount Sinai Medical Center Miami Beach, Florida, United States
View Trial Details
Completed

S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma

NCT00040937

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California Davis Cancer Center Davis, California, United States
  • Sutter Roseville Medical Center Roseville, California, United States
  • Sutter Cancer Center Sacramento, California, United States
View all 141 locations
View Trial Details
Completed

Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation.

NCT00306735

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Indiana Blood and Marrow Transplantation Beech Grove, Indiana, United States
  • Cornell Medical Center New York, United States
  • Wake Forest Medical Center Winston-Salem, North Carolina, United States
  • Oregon Health & Science University Portland, Oregon, United States
View Trial Details
Completed

A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)

NCT01804140

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Sedona, Arizona, United States
  • Tucson, Arizona, United States
  • Burbank, California, United States
  • Rancho Cucamonga, California, United States
View all 20 locations
View Trial Details

Related conditions